Home » Topics » BioWorld Science

BioWorld Science
RSS

TG Therapeutics initiates first-in-human study of its anti-CD47/CD19 bispecific antibody TG-1801

Feb. 27, 2019

Imbrium Therapeutics and TetraGenetics collaborate to develop novel biologic therapeutics for pain

Feb. 27, 2019

H3 Biomedicine publishes preclinical pharmacokinetics and metabolism data on H3B-6545

Feb. 27, 2019

Alternative energy for metabolic brain disorder

Feb. 27, 2019

Staph toxins' DARC arts: Targeting blood vessels

Feb. 27, 2019

Debiopharm begins phase II study of afabicin for staphylococcal bone and joint infections

Feb. 26, 2019

Favorable interim phase I results for SRK-015 support progression to phase II for SMA

Feb. 26, 2019

Modified mRNA encoding VEGF-A evaluated in patients with type 2 diabetes

Feb. 26, 2019

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

New phase I trial evaluates MK-8527 in ART-naive patients with HIV-1

Feb. 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...